Giridharan Gokulrangan

Giridharan Gokulrangan is a seasoned Senior Principal Scientist currently with AbbVie since August 2024, bringing extensive experience in bioanalysis and drug metabolism and pharmacokinetics (DMPK). Previously, Gokulrangan served as Senior Principal Scientist and Principal Scientist at Cerevel Therapeutics from January 2021 to August 2024. Gokulrangan's background includes a tenure as Senior Research Investigator at Bristol-Myers Squibb from July 2015 to December 2020, focusing on mass spectrometry-based bioanalytical research, and as a Senior Biological Mass Spectrometry Scientist at Pfizer from July 2014 to June 2015. Earlier experience includes a role as Lead Mass Spectrometrist and Senior Research Scientist at the Center for Proteomics and Bioinformatics, Case Western Reserve University, from September 2007 to May 2014. Gokulrangan earned a Ph.D. in Bioanalytical Chemistry from The University of Kansas and holds a degree from Vivekananda College, University of Madras, India.